Gene testing to detect kidney transplant rejection in young people
Part of Kidney & urinary clinical trials.
This study looks at how genes in the kidney change when the body might be rejecting the transplant. By studying these genes, doctors hope to find better ways to detect kidney rejection early and help keep the kidney healthy longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be 21 years old or younger.
- You must have received a single kidney transplant (from a living or deceased donor).
- If you received a transplant of more than one organ (like a kidney and pancreas), you cannot join this study.
- You must be willing to give written consent (for minors, a parent or guardian must consent).
- A kidney biopsy must be done with enough tissue to study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study looks at the genes of people who have had or will have a kidney transplant. It aims to learn how genetic information might help improve transplant care over time. Participants will give blood, urine, stool, and possibly kidney tissue samples for research.
This study looks at special blood tests to help predict when kidney transplant rejection might happen. If the markers work, they could help doctors catch rejection earlier and adjust treatment sooner.
Hear when a new Kidney Rejection Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.